Figure 3.
![Overall survival in patients with B-PLL. Panels A-B as a function of MYC aberrations [t(MYC) or gain] and the presence or absence of MYC aberration; the t(MYC) and MYC gain data were pooled. (A) t(MYC) median (95% CI), 57.5 months (25.7-132.1); MYC gain median (95% CI), 66.5 months (4.7-undetermined). (B) MYC aberration [t(MYC) + MYC gain] median (95% CI), 57.5 (25.7-132.1). (C) MYC and del17p status. MYC aberration without del17p median (95% CI), 125.7 months (52.2-132.1); MYC aberration with del17p median (95% CI), 11.1 months (4.7-66.5). ab, aberration.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/134/21/10.1182_blood.2019001187/7/bloodbld2019001187f3.png?Expires=1721126049&Signature=NdlY10TpIXT3SqHMe5j6tJX5-zBzDW7kQYNLJmqm-XXeBN2M1cf8FKyE8Wz6mEGLdPgjTKp9QEsaTxi1Yjn3Nj-Agmd3OMCXu8eYyN5JyQjDSexvJbjrTJLUBL0iX9nu3XU2N31hN9kC~OKgRS9x0aEBA5Lywx~Pop8~w4BTk3EpPai1ZrREZXEs-DkHMlB6iOSgpQ8jyA0wxTdr0IeKC-2HCmZBzsriqqBHSdU0Oyf64sHe6Qr0hAelChfE4RVdANLaVSj2HJNyt9-Ms3EZTPH1TEAIe-XCKt--fi1c17AL6iqjR1wyhXNMMQKVUnYhIDKR2X8OW4lUmbSDZqT1LQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Overall survival in patients with B-PLL. Panels A-B as a function of MYC aberrations [t(MYC) or gain] and the presence or absence of MYC aberration; the t(MYC) and MYC gain data were pooled. (A) t(MYC) median (95% CI), 57.5 months (25.7-132.1); MYC gain median (95% CI), 66.5 months (4.7-undetermined). (B) MYC aberration [t(MYC) + MYC gain] median (95% CI), 57.5 (25.7-132.1). (C) MYC and del17p status. MYC aberration without del17p median (95% CI), 125.7 months (52.2-132.1); MYC aberration with del17p median (95% CI), 11.1 months (4.7-66.5). ab, aberration.